Available at research and GMP grade to intensify production of recombinant AAV rAAV viral vectors at any scale from benchtop to 2000L scale bioreactor...
![](https://www.polyplus-sartorius.com/wp-content/uploads/2020/03/FectoVIR-AAV-435x242.png)
Participants: Cassie-Marie Peigné, Scientific Support Specialist, Polyplus-transfection. Alan Dickson, Professor of Biotechnology at Centre of Excellence in Biopharmaceuticals, University of Manchester. Hélène Trottin, Senior Technical Specialist, Process Sciences at Pharmaron Gene Therapy.
This webinar will discuss some of the key upstream process parameters to consider for efficient and scalable AAV production with a focus on the transfection step.
Key messages:
Source: Pharmaron Gene therapy.
Fill out the form below to watch Webinar “Upstream AAV production: A Targeted Approach To Optimization”